Abstract:Retinoic acid (RA) is known to regulate definitive myelopoiesis but its role in vertebrate primitive myelopoiesis remains unclear. Here we report that zebrafish primitive myelopoiesis is restricted by RA in a dose dependent manner mainly before 11 hpf (hours post fertilization) when anterior hemangioblasts are initiated to form. RA treatment significantly reduces expressions of anterior hemangioblast markers scl, lmo2, gata2 and etsrp in the rostral end of ALPM (anterior lateral plate mesoderm) of the embryos. The result indicates that RA restricts primitive myelopoiesis by suppressing formation of anterior hemangioblasts. Analyses of ALPM formation suggest that the defective primitive myelopoiesis resulting from RA treatment before late gastrulation may be secondary to global loss of cells for ALPM fate whereas the developmental defect resulting from RA treatment during 10-11 hpf should be due to ALPM patterning shift. Overexpressions of scl and lmo2 partially rescue the block of primitive myelopoiesis in the embryos treated with 250 nM RA during 10-11 hpf, suggesting RA acts upstream of scl to control primitive myelopoiesis. However, the RA treatment blocks the increased primitive myelopoiesis caused by overexpressing gata4/6 whereas the abolished primitive myelopoiesis in gata4/5/6 depleted embryos is well rescued by 4-diethylamino-benzaldehyde, a retinal dehydrogenase inhibitor, or partially rescued by knocking down aldh1a2, the major retinal dehydrogenase gene that is responsible for RA synthesis during early development. Consistently, overexpressing gata4/6 inhibits aldh1a2 expression whereas depleting gata4/5/6 increases aldh1a2 expression. The results reveal that RA signaling acts downstream of gata4/5/6 to control primitive myelopoiesis. But, 4-diethylamino-benzaldehyde fails to rescue the defective primitive myelopoiesis in either cloche embryos or lycat morphants. Taken together, our results demonstrate that RA signaling restricts zebrafish primitive myelopoiesis through acting downstream of gata4/5/6, upstream of, or parallel to, cloche, and upstream of scl.

Retinoic acid signaling in vascular development

Mechanisms of retinoic acid signalling and its roles in organ and limb development

Retinoic acid signaling in development and differentiation commitment and its regulatory topology

Towards a Better Vision of Retinoic Acid Signaling during Eye Development

Interaction of Retinoic Acid and Scl Controls Primitive Blood Development

Wnt Signaling Modulates Routes of Retinoic Acid-Induced Differentiation of Embryonic Stem Cells

Retinoic acid synthesis and functions in early embryonic development

Retinoic acid signaling and neuronal differentiation

Retinoic acid synthesis and autoregulation mediate zonal patterning of vestibular organs and inner ear morphogenesis

Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis

VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels

Retinoic Acid Enhances the Generation of Hematopoietic Progenitors from Human Embryonic Stem Cell–derived Hemato-Vascular Precursors

Retinoic Acid Signaling Plays a Restrictive Role in Zebrafish Primitive Myelopoiesis

Retinoic Acid Signaling is Essential for Valvulogenesis by Affecting Endocardial Cushions Formation in Zebrafish Embryos.

Retinoic Acid Regulates Bone Morphogenic Protein Signal Duration By Promoting The Degradation Of Phosphorylated Smad1

The Role of Wnt Signaling in Physiological and Pathological Angiogenesis

Differential Response of Human Fetal Smooth Muscle Cells from Arterial Duct to Retinoid Acid

Vascular endothelial growth factor signaling in development and disease

Retinoic acid signaling within pancreatic endocrine progenitors regulates mouse and human β cell specification

Molecular Mechanisms of Retinoic Acid Action

Retinoic Acid-Mediated Control of Energy Metabolism is Essential for Lung Branching Morphogenesis